当前位置： SCI文献检索 > EJNMMI Research期刊下所有文献 > Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.

Abstract：

BACKGROUND:Hypoxic tumours exhibit increased resistance to radiation, chemical, and immune therapies. 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) is a non-invasive, quantitative imaging technique used to evaluate the presence and spatial distribution of tumour hypoxia. To facilitate the use of FMISO PET for identification of individuals likely to benefit from hypoxia-targeted treatments, we investigated the reproducibility of FMISO PET spatiotemporal intratumour distribution in patients with non-small cell lung cancer (NSCLC). METHODS:Ten patients underwent 18F-fluorodeoxyglucose (FDG) PET/CT scans, followed by two FMISO PET/CT scans 1-2 days apart. Nineteen lesions in total were segmented from co-registered FDG PET image sets. Volumes of interest were also defined on normal contralateral lung and subscapularis muscle. The Pearson correlation coefficient r was calculated for mean standardized uptake values (SUV) within investigated volumes of interest and for voxels within tumour volumes (r TV). The reproducibility of FMISO voxelwise distribution, SUV- and tumour-to-blood ratio (TBR)-derived indices was assessed using correlation and Bland-Altman analyses. RESULTS:The SUVmax, SUVmean, TBRmax, and TBRmean were highly correlated (r ≥ 0.87, p < 0.001) and were reproducible to within 10-15 %. The mean r TV was 0.84 ± 0.10. 77 % of voxels identified as hypoxic on one FMISO scan were confirmed as such on the other FMISO scan. Mean voxelwise differences between TBR values as calculated from pooled data including all lesions were 0.9 ± 10.8 %. CONCLUSIONS:High reproducibility of FMISO intratumour distribution in NSCLC patients was observed, facilitating its use in determining the topology of the hypoxic tumour sub-volumes for dose escalation, in patient stratification strategies for hypoxia-targeted therapies, and in monitoring response to therapeutic interventions. TRIAL REGISTRATION:Current Controlled Trials NCT02016872.

journal_name

EJNMMI Res

journal_title

EJNMMI research

authors

Grkovski M,Schwartz J,Rimner A,Schöder H,Carlin SD,Zanzonico PB,Humm JL,Nehmeh SA

doi

10.1186/s13550-016-0210-y

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

79

issue

1

issn

2191-219X

pii

10.1186/s13550-016-0210-y

journal_volume

6

pub_type

杂志文章

相关文献

EJNMMI Research文献大全
  • SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

    abstract：BACKGROUND:Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is 177Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma photons by 177Lu allows ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-017-0262-7

    authors： Gustafsson J,Sundlöv A,Sjögreen Gleisner K

    更新日期：2017-12-01 00:00:00

  • Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity.

    abstract：BACKGROUND:Over the last decade, a few radioligands have been developed for PET imaging of brain 5-HT1B receptors. The 5-HT1B receptor is a G-protein-coupled receptor (GPCR) that exists in two different agonist affinity states. An agonist ligand is expected to be more sensitive towards competition from another agonist,...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-019-0570-1

    authors： Lindberg A,Arakawa R,Nogami T,Nag S,Schou M,Elmore CS,Farde L,Pike VW,Halldin C

    更新日期：2019-11-21 00:00:00

  • 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.

    abstract：BACKGROUND:Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, but majority of patients develop disease recurrence following ADT. There is therefore an urgent need for early detection of treatment resistance. METHODS:Isogenic ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-00728-9

    authors： Malviya G,Patel R,Salji M,Martinez RS,Repiscak P,Mui E,Champion S,Mrowinska A,Johnson E,AlRasheedi M,Pimlott S,Lewis D,Leung HY

    更新日期：2020-11-25 00:00:00

  • Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.

    abstract：BACKGROUND:Non-small cell lung carcinoma (NSCLC) represents approximately 80% of lung cancer cases, and over 60% of these tumors express the epidermal growth factor receptor (EGFR). Activating mutations in the tyrosine kinase (TK) domain of the EGFR are detected in 10% to 30% of NSCLC patients, and evidence of their pr...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-014-0080-0

    authors： Abourbeh G,Itamar B,Salnikov O,Beltsov S,Mishani E

    更新日期：2015-02-12 00:00:00

  • Gut microbiota and physiologic bowel 18F-FDG uptake.

    abstract：BACKGROUND:We investigated the association between physiologic bowel FDG uptake and gut microbiota. FDG uptake in the normal large and small intestine is widely variable both in distribution and intensity. The etiology of physiologic bowel 18F-FDG activity remains unknown. RESULTS:We included 63 healthy male subjects....

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-017-0318-8

    authors： Kang JY,Kim HN,Chang Y,Yun Y,Ryu S,Shin H,Kim HL

    更新日期：2017-08-31 00:00:00

  • Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients.

    abstract：BACKGROUND:Assessment of liver function is critical in hepatocellular carcinoma (HCC) patient management. We evaluated parameters of [(99m)Tc] sulfur colloid (SC) SPECT/CT liver uptake for association with clinical measures of liver function and outcome in HCC patients. METHODS:Thirty patients with HCC and variable Ch...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-016-0212-9

    authors： Bowen SR,Chapman TR,Borgman J,Miyaoka RS,Kinahan PE,Liou IW,Sandison GA,Vesselle HJ,Nyflot MJ,Apisarnthanarax S

    更新日期：2016-12-01 00:00:00

  • Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice.

    abstract：BACKGROUND:Small-cell lung carcinoma (SCLC) is an aggressive malignancy characterised by an early relapse, a tendency towards drug resistance, and a high incidence of metastasis. SCLC cells are of neuroendocrine origin and express high levels of somatostatin receptors; therefore, future treatment might involve targetin...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-1-19

    authors： Erlandsson A,Forssell-Aronsson E,Seidal T,Bernhardt P

    更新日期：2011-08-26 00:00:00

  • Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT.

    abstract：:An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title：EJNMMI research

    pub_type： 已发布勘误

    doi：10.1186/s13550-020-00719-w

    authors： Ross MI,Bird N,Mendichovszky IA,Rimmer YL

    更新日期：2020-10-27 00:00:00

  • Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.

    abstract：BACKGROUND:Molecular breast imaging (MBI) performed with 99mTc sestamibi has been shown to be a valuable technique for the detection of breast cancer. Alternative radiotracers such as 99mTc maraciclatide may offer improved uptake in breast lesions. The purpose of this study was to compare relative performance of 99mTc ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-017-0255-6

    authors： O'Connor MK,Morrow MMB,Hunt KN,Boughey JC,Wahner-Roedler DL,Conners AL,Rhodes DJ,Hruska CB

    更新日期：2017-12-01 00:00:00

  • Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.

    abstract：BACKGROUND:The availability of GABAA receptor binding sites in the brain can be assessed by positron emission tomography (PET) using the radioligand, [18F]flumazenil. However, the brain uptake and binding of this PET radioligand are influenced by anesthetic drugs, which are typically needed in preclinical imaging studi...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-016-0235-2

    authors： Palner M,Beinat C,Banister S,Zanderigo F,Park JH,Shen B,Hjoernevik T,Jung JH,Lee BC,Kim SE,Fung L,Chin FT

    更新日期：2016-12-01 00:00:00

  • Imaging of the appearance time of cerebral blood using [15O]H2O PET for the computation of correct CBF.

    abstract：BACKGROUND:Quantification of cerebral blood flow (CBF) is important for the understanding of normal and pathologic brain physiology. Positron emission tomography (PET) with H215O (or C15O2) can quantify CBF and apply kinetic analyses, including autoradiography (ARG) and the basis function methods (BFM). These approache...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-3-41

    authors： Kudomi N,Maeda Y,Sasakawa Y,Monden T,Yamamoto Y,Kawai N,Iida H,Nishiyama Y

    更新日期：2013-05-23 00:00:00

  • Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc.

    abstract：BACKGROUND:In molecular imaging and nuclear medicine, theranostic agents that integrate radionuclide pairs are successfully being used for individualized care, which has led to rapidly growing interest in their continued development. These compounds, which are radiolabeled with one radionuclide for imaging and a chemic...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-019-0515-8

    authors： Loveless CS,Radford LL,Ferran SJ,Queern SL,Shepherd MR,Lapi SE

    更新日期：2019-05-16 00:00:00

  • Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

    abstract：BACKGROUND:177Lu-[DOTA0, Tyr3]-octreotate (177Lu-octreotate) is used for treatment of patients with somatostatin receptor (SSTR) expressing neuroendocrine tumors. However, complete tumor remission is rarely seen, and optimization of treatment protocols is needed. In vitro studies have shown that irradiation can up-regu...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-016-0247-y

    authors： Dalmo J,Spetz J,Montelius M,Langen B,Arvidsson Y,Johansson H,Parris TZ,Helou K,Wängberg B,Nilsson O,Ljungberg M,Forssell-Aronsson E

    更新日期：2017-12-01 00:00:00

  • Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients.

    abstract：BACKGROUND:The positron emission tomography (PET) ligand 68Ga-Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11) targets the prostate-specific membrane antigen (PSMA), upregulated in prostate cancer cells. Although 68Ga-PSMA-11 PET is widely used in research and clinical practice, full kinetic modeling has not yet been reported ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-0594-6

    authors： Ringheim A,Campos Neto GC,Anazodo U,Cui L,da Cunha ML,Vitor T,Martins KM,Miranda ACC,de Barboza MF,Fuscaldi LL,Lemos GC,Colombo Junior JR,Baroni RH

    更新日期：2020-02-24 00:00:00

  • Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer.

    abstract：BACKGROUND:To assess 18-fluorodeoxyglucose (FDG) bowel uptake in patients with differentiated thyroid cancer (DTC) treated with sorafenib. FINDINGS:Visual (5-point scale) and high maximum standard uptake value (SUVmax) semi-quantitative analyses were conducted in 63 positron emission tomography (PET) studies performed...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-2-18

    authors： Ciappuccini R,Trzepla G,Heutte N,Sevin E,Galais MP,Bardet S

    更新日期：2012-05-07 00:00:00

  • The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

    abstract：BACKGROUND:The G-protein-coupled receptor 44 (GPR44) is a beta cell-restricted target that may serve as a marker for beta cell mass (BCM) given the development of a suitable PET ligand. METHODS:The binding characteristics of the selected candidate, AZ12204657, at human GPR44 were determined using in vitro ligand bindi...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-018-0465-6

    authors： Jahan M,Johnström P,Selvaraju RK,Svedberg M,Winzell MS,Bernström J,Kingston L,Schou M,Jia Z,Skrtic S,Johansson L,Korsgren O,Farde L,Halldin C,Eriksson O

    更新日期：2018-12-27 00:00:00

  • Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.

    abstract：BACKGROUND:In the present study, we used multimodal imaging to investigate biodistribution in rats after intravenous administration of a new 99mTc-labeled delivery system consisting of polymer-shelled microbubbles (MBs) functionalized with diethylenetriaminepentaacetic acid (DTPA), thiolated poly(methacrylic acid) (PMA...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-3-12

    authors： Barrefelt AA,Brismar TB,Egri G,Aspelin P,Olsson A,Oddo L,Margheritelli S,Caidahl K,Paradossi G,Dähne L,Axelsson R,Hassan M

    更新日期：2013-02-25 00:00:00

  • Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response.

    abstract：BACKGROUND:There is a growing interest in the use of F-18 FDG PET-CT to monitor tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and diffuse, with dynamic changes during treatment and persisting metabolic activity after apparent clinical cure. This poses a challenge in quantifying scan-...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-0591-9

    authors： Malherbe ST,Chen RY,Dupont P,Kant I,Kriel M,Loxton AG,Smith B,Beltran CGG,van Zyl S,McAnda S,Abrahams C,Maasdorp E,Doruyter A,Via LE,Barry CE 3rd,Alland D,Richards SG,Ellman A,Peppard T,Belisle J,Tromp G,Ronache

    更新日期：2020-02-10 00:00:00

  • The effect of isoflurane on 18F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation.

    abstract：BACKGROUND:In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer kinetics under study, and the nature of these effects is usually not known. METHOD:We have impleme...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-016-0242-3

    authors： Spangler-Bickell MG,de Laat B,Fulton R,Bormans G,Nuyts J

    更新日期：2016-12-01 00:00:00

  • Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry.

    abstract：BACKGROUND:Fluorine-18 fluoroethoxybenzovesamicol ([18F]FEOBV) is a radioligand for the selective imaging of the vesicular acetylcholine transporter with positron emission tomography (PET). The current study demonstrates that pathological cortical cholinergic deafferentation can be quantified in vivo with [18F]FEOBV PE...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-3-70

    authors： Parent MJ,Cyr M,Aliaga A,Kostikov A,Schirrmacher E,Soucy JP,Mechawar N,Rosa-Neto P,Bedard MA

    更新日期：2013-10-09 00:00:00

  • Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis.

    abstract：BACKGROUND:F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising modality for detecting active lesions of cardiac sarcoidosis (CS). However, determining whether 18F-FDG uptake in the myocardium is physiological is challenging due to metabolic shift in myocardial cells. Although methods for inhibi...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-4-1

    authors： Morooka M,Moroi M,Uno K,Ito K,Wu J,Nakagawa T,Kubota K,Minamimoto R,Miyata Y,Okasaki M,Okazaki O,Yamada Y,Yamaguchi T,Hiroe M

    更新日期：2014-01-02 00:00:00

  • Radiofluorination using aluminum-fluoride (Al18F).

    abstract：:Targeted agents are increasingly used for treating cancer and other diseases, but patients may need to be carefully selected to maximize the potential for therapeutic benefit. One way to select patients is to bind an imaging radionuclide to a targeting agent of interest, so that its uptake in specific sites of disease...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-3-36

    authors： McBride WJ,Sharkey RM,Goldenberg DM

    更新日期：2013-05-08 00:00:00

  • Double-strand breaks in lymphocyte DNA of humans exposed to [18F]fluorodeoxyglucose and the static magnetic field in PET/MRI.

    abstract：BACKGROUND:Given the increasing clinical use of PET/MRI, potential risks to patients from simultaneous exposure to ionising radiation and (electro)magnetic fields should be thoroughly investigated as a precaution. With this aim, the genotoxic potential of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and a strong static m...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-00625-1

    authors： Brix G,Günther E,Rössler U,Endesfelder D,Kamp A,Beer A,Eiber M

    更新日期：2020-04-28 00:00:00

  • Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1).

    abstract：PURPOSE:Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is overexpressed in solid tumours, including prostate cancer (PCa). This st...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-00637-x

    authors： Yeh MC,Tse BWC,Fletcher NL,Houston ZH,Lund M,Volpert M,Stewart C,Sokolowski KA,Jeet V,Thurecht KJ,Campbell DH,Walsh BJ,Nelson CC,Russell PJ

    更新日期：2020-05-07 00:00:00

  • Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy.

    abstract：PURPOSE:To investigate the added value and diagnostic accuracy of 68Ga-PSMA PET/CT versus bone scintigraphy (BS) for bone metastasis detection at the primary staging of prostate cancer (PCa). METHODS:Inclusion criteria involved consecutive patients with newly diagnosed intermediate- to high-risk PCa, who had undergone...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-00618-0

    authors： Zacho HD,Ravn S,Afshar-Oromieh A,Fledelius J,Ejlersen JA,Petersen LJ

    更新日期：2020-04-08 00:00:00

  • Detection of murine post-pneumonectomy lung regeneration by 18FDG PET imaging.

    abstract：UNLABELLED: BACKGROUND:An intriguing biologic process in most adult mammals is post-pneumonectomy lung regeneration, that is, the removal of one lung (pneumonectomy) results in the rapid compensatory growth of the remaining lung. The spatial dependence and metabolic activity of the rodent lung during compensatory lung...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-2-48

    authors： Gibney BC,Park MA,Chamoto K,Ysasi A,Konerding MA,Tsuda A,Mentzer SJ

    更新日期：2012-09-21 00:00:00

  • 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study.

    abstract：BACKGROUND:Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis. We present a radiolabelling method for certolizumab pegol (CZP), a commercially available humanized Fab'-fragment directed against TNF. A biodistribution and do...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-016-0245-0

    authors： Lambert B,Carron P,D'Asseler Y,Bacher K,Van den Bosch F,Elewaut D,Verbruggen G,Beyaert R,Dumolyn C,De Vos F

    更新日期：2016-12-01 00:00:00

  • Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

    abstract：UNLABELLED: BACKGROUND:Iodine-123-β-CIT, a single-photon emission computed tomography (SPECT) ligand for dopamine transporters (DATs), has been used for in vivo studies in humans, monkeys, and rats but has not yet been used extensively in mice. To validate the imaging and analysis methods for preclinical DAT imaging, ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/2191-219X-2-55

    authors： Pitkonen M,Hippeläinen E,Raki M,Andressoo JO,Urtti A,Männistö PT,Savolainen S,Saarma M,Bergström K

    更新日期：2012-09-29 00:00:00

  • Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients.

    abstract：BACKGROUND:Hepatobiliary scintigraphy using (99m)Tc-mebrofenin has been used as an investigation to study liver function after liver transplantation (LTx). Hepatic extraction fraction (HEF) is a measurement of the hepatic extraction efficiency and hepatic extraction rate. With the purpose of evaluating a possible diver...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-014-0073-z

    authors： Kaxiras A,Yamamoto S,Söderdahl G,Wernerson A,Axelsson R,Ericzon BG

    更新日期：2014-12-01 00:00:00

  • A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting.

    abstract：BACKGROUND:Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for imaging and treatment of neuroendocrine tumors. Owing to the concomitant and heterogeneous expression of several subtypes on the same tumor, analogs targeting more subtypes ...

    journal_title：EJNMMI research

    pub_type： 杂志文章

    doi：10.1186/s13550-020-00677-3

    authors： Mansi R,Abid K,Nicolas GP,Del Pozzo L,Grouzmann E,Fani M

    更新日期：2020-08-05 00:00:00